EdgeMarketInstruments › COEP

COEP — Coeptis Therapeutics Holdings Inc. Common Stock

US equity

No longer trading — kept for point-in-time research

16.40 +1.17% today
USD · as of 2026-04-24

Price · 2024-08-26 → 2026-04-24

417 daily closes shown
52w low 7.05 · high 18.80

Anonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2022-10-31.

Performance

1 day+1.17%
1 week+11.95%
1 month+46.56%
3 months+17.14%
6 months+9.37%
Year to date+12.02%
1 year+42.61%
3 years-42.25%

Technicals

RSI 1474.2
vs 50-day avg+33.77%
vs 200-day avg+20.77%
Volatility 1y90.3%
Max drawdown 1y-44.68%
Avg volume 30d53.3K
Daily bars held873
History from2022-10-31

Largest institutional holders

managervalueshares
VANGUARD CAPITAL MANAGEMENT LLC3.6M320.7K
GEODE CAPITAL MANAGEMENT, LLC596.1K53.1K
STATE STREET CORP301.0K26.8K
VANGUARD FIDUCIARY TRUST CO275.7K24.6K
UNITED CAPITAL FINANCIAL ADVISORS, LLC224.4K20.0K
BlackRock, Inc.152.2K13.6K
NORTHERN TRUST CORP137.1K12.2K
Steward Partners Investment Advisory, LLC56.1K5.0K
Vanguard Global Advisers, LLC18.7K1.7K
MORGAN STANLEY2.3K201

13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →

Ask the AI about COEP

The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.

Open COEP in the terminal → How the AI works

Everything on this page is live in the terminal.

Charts, filings, insider flow and the AI — open without an account.

Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →